tradingkey.logo

STAAR Surgical Co

STAA
27.400USD
-0.010-0.04%
Cierre 11/11, 16:00ETCotizaciones retrasadas 15 min
1.35BCap. mercado
PérdidaP/E TTM

STAAR Surgical Co

27.400
-0.010-0.04%

Más Datos de STAAR Surgical Co Compañía

STAAR Surgical Company designs, develops, manufactures, and sells implantable lenses for the eye and accessory delivery systems used to deliver the lenses into the eye. These lenses provide visual freedom for patients, lessening or eliminating the reliance on glasses or contact lenses. The Company is a manufacturer of lenses used worldwide in corrective or refractive surgery. It sells its products in approximately 75 countries, with direct distribution in Japan, Germany, Spain, the United States, Canada, the United Kingdom, and Singapore, with a combination of direct distribution and independent distribution in China, Korea, India, France, Benelux, and Italy. The Company markets and sells ICLs for refractive surgery to treat myopia (nearsightedness) as its EVO family of lenses. The Company’s EVO family of lenses includes its EVO ICL, EVO+ ICL, and EVO Visian ICL. The Company also markets and sells an ICL lens to treat hyperopia (farsightedness), which is called Visian ICL.

Información de STAAR Surgical Co

Símbolo de cotizaciónSTAA
Nombre de la empresaSTAAR Surgical Co
Fecha de salida a bolsaFeb 24, 1992
Director ejecutivoMr. Stephen C. (Steve) Farrell, CPA
Número de empleados1157
Tipo de seguridadOrdinary Share
Fin del año fiscalFeb 24
Dirección1911 Walker Ave
CiudadMONROVIA
Bolsa de valoresNASDAQ Global Market Consolidated
PaísUnited States of America
Código postal91016
Teléfono16263037902
Sitio Webhttps://www.staar.com/
Símbolo de cotizaciónSTAA
Fecha de salida a bolsaFeb 24, 1992
Director ejecutivoMr. Stephen C. (Steve) Farrell, CPA

Ejecutivos de STAAR Surgical Co

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Stephen C. (Steve) Farrell, CPA
Mr. Stephen C. (Steve) Farrell, CPA
Chief Executive Officer, Director
Chief Executive Officer, Director
35.16K
--
Mr. Wei Jiang
Mr. Wei Jiang
Director
Director
25.57K
--
Mr. Warren Foust
Mr. Warren Foust
President, Chief Operating Officer
President, Chief Operating Officer
19.31K
--
Mr. Nathaniel B. Sisitsky, Esq.
Mr. Nathaniel B. Sisitsky, Esq.
Chief Legal Officer and Corporate Secretary
Chief Legal Officer and Corporate Secretary
10.80K
--
Dr. Magda Michna, Ph.D.
Dr. Magda Michna, Ph.D.
Chief Development Officer
Chief Development Officer
9.76K
--
Ms. Deborah J. Andrews
Ms. Deborah J. Andrews
Chief Financial Officer
Chief Financial Officer
8.59K
--
Dr. Elizabeth Yeu, M.D.
Dr. Elizabeth Yeu, M.D.
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
5.10K
--
Mr. Louis E. (Lou) Silverman
Mr. Louis E. (Lou) Silverman
Independent Director
Independent Director
475.00
--
Ms. Lilian Zhou
Ms. Lilian Zhou
Independent Director
Independent Director
--
--
Mr. Brian Moore
Mr. Brian Moore
Vice President - Investor Relations and Corporate Development
Vice President - Investor Relations and Corporate Development
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Stephen C. (Steve) Farrell, CPA
Mr. Stephen C. (Steve) Farrell, CPA
Chief Executive Officer, Director
Chief Executive Officer, Director
35.16K
--
Mr. Wei Jiang
Mr. Wei Jiang
Director
Director
25.57K
--
Mr. Warren Foust
Mr. Warren Foust
President, Chief Operating Officer
President, Chief Operating Officer
19.31K
--
Mr. Nathaniel B. Sisitsky, Esq.
Mr. Nathaniel B. Sisitsky, Esq.
Chief Legal Officer and Corporate Secretary
Chief Legal Officer and Corporate Secretary
10.80K
--
Dr. Magda Michna, Ph.D.
Dr. Magda Michna, Ph.D.
Chief Development Officer
Chief Development Officer
9.76K
--
Ms. Deborah J. Andrews
Ms. Deborah J. Andrews
Chief Financial Officer
Chief Financial Officer
8.59K
--

Desglose de ingresos

Divisa: USDActualizado: lun., 6 de oct
Divisa: USDActualizado: lun., 6 de oct
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
Sin datos
Por regiónUSD
Nombre
Ganancia
Proporción
Others
18.18M
41.02%
Japan
10.91M
24.63%
U. S.
5.63M
12.71%
China
5.30M
11.96%
South Korea
4.29M
9.69%
Por negocio
Por región
Sin datos

Estadísticas de accionistas

Actualizado: mar., 11 de nov
Actualizado: mar., 11 de nov
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Broadwood Capital, Inc.
27.18%
BlackRock Institutional Trust Company, N.A.
13.50%
The Vanguard Group, Inc.
8.56%
Armistice Capital LLC
5.65%
Yunqi Capital Limited
5.03%
Otro
40.08%
Accionistas
Accionistas
Proporción
Broadwood Capital, Inc.
27.18%
BlackRock Institutional Trust Company, N.A.
13.50%
The Vanguard Group, Inc.
8.56%
Armistice Capital LLC
5.65%
Yunqi Capital Limited
5.03%
Otro
40.08%
Tipos de accionistas
Accionistas
Proporción
Hedge Fund
44.85%
Investment Advisor
32.99%
Investment Advisor/Hedge Fund
13.54%
Research Firm
5.07%
Pension Fund
1.07%
Bank and Trust
0.58%
Individual Investor
0.46%
Venture Capital
0.08%
Insurance Company
0.04%
Otro
1.31%

Participación institucional

Actualizado: mié., 1 de oct
Actualizado: mié., 1 de oct
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q3
511
49.83M
100.45%
-14.96M
2025Q2
543
53.99M
109.59%
-5.64M
2025Q1
586
53.67M
108.47%
-5.73M
2024Q4
611
49.68M
100.75%
-8.34M
2024Q3
633
50.35M
102.36%
-6.37M
2024Q2
636
49.69M
101.15%
-10.70M
2024Q1
632
50.54M
103.45%
-9.24M
2023Q4
640
52.70M
107.96%
-9.84M
2023Q3
658
55.47M
114.38%
-3.16M
2023Q2
667
52.64M
108.92%
-2.50M
Ver más

Actividad de los accionistas

Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Broadwood Capital, Inc.
13.52M
27.39%
--
--
Sep 24, 2025
BlackRock Institutional Trust Company, N.A.
6.72M
13.61%
-298.81K
-4.26%
Jun 30, 2025
The Vanguard Group, Inc.
4.38M
8.88%
-1.02M
-18.96%
Jun 30, 2025
Armistice Capital LLC
2.81M
5.7%
-188.00K
-6.27%
Jun 30, 2025
Yunqi Capital Limited
2.50M
5.07%
+88.77K
+3.68%
Sep 19, 2025
State Street Investment Management (US)
2.00M
4.06%
+7.97K
+0.40%
Jun 30, 2025
Geode Capital Management, L.L.C.
1.19M
2.42%
+3.33K
+0.28%
Jun 30, 2025
BofA Global Research (US)
1.15M
2.32%
+193.56K
+20.30%
Jun 30, 2025
Morgan Stanley & Co. LLC
873.98K
1.77%
+393.30K
+81.82%
Jun 30, 2025
Ver más

ETFs relacionados

Actualizado: jue., 6 de nov
Actualizado: jue., 6 de nov
Nombre
Proporción
AltShares Event-Driven ETF
3.35%
AltShares Merger Arbitrage ETF
2.71%
ProShares Merger ETF
2.37%
SPDR S&P Health Care Equipment ETF
1.59%
NYLI Merger Arbitrage ETF
0.87%
Invesco S&P SmallCap Health Care ETF
0.85%
Royce Quant Small-Cap Quality Value ETF
0.3%
SPDR S&P SmallCap 600 ESG ETF
0.13%
iShares S&P Small-Cap 600 Growth ETF
0.1%
SPDR S&P 600 Small Cap Growth ETF
0.1%
Ver más
AltShares Event-Driven ETF
Proporción3.35%
AltShares Merger Arbitrage ETF
Proporción2.71%
ProShares Merger ETF
Proporción2.37%
SPDR S&P Health Care Equipment ETF
Proporción1.59%
NYLI Merger Arbitrage ETF
Proporción0.87%
Invesco S&P SmallCap Health Care ETF
Proporción0.85%
Royce Quant Small-Cap Quality Value ETF
Proporción0.3%
SPDR S&P SmallCap 600 ESG ETF
Proporción0.13%
iShares S&P Small-Cap 600 Growth ETF
Proporción0.1%
SPDR S&P 600 Small Cap Growth ETF
Proporción0.1%

Dividendos

Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos

División de acciones

Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
KeyAI